Annual Report
Our report on activities & financial performance throughout the year.
June 9, 2022
1:00 p.m. PT
eFFECTOR was founded on pioneering research in the laboratories of Drs. Davide Ruggero and Kevan Shokat and subsequently licensed proprietary applications of translational profiling technology from the University of California, San Francisco. Our scientific founders and management team comprise industry veterans who have played important roles in the discovery and development of marketed small molecule drugs, monoclonal antibody therapeutics and cellular immunotherapies in oncology and other disease areas.
Powered by Donnelley Financial Solutions.
Copyright © 2022 Mediant Communications Inc. All Rights Reserved.